López-Domínguez Jaime, López-Monteon Aracely, Ochoa-Martínez Paulina, González-García Josue Rafael, Peña-Rodríguez Rodolfo, Waleckx Etienne, Moo-Millán Joel, Ramos-Ligonio Angel
LADISER Inmunología y Biología Molecular, Edificio D, Facultad de Ciencias Químicas, Universidad Veracruzana (UV), Prolongación de Oriente 6 #1009, Colonia Rafael Alvarado, C.P. 94340, 86039, Orizaba, Veracruz, Mexico.
Asociacion Chagas con Ciencia y Conocimiento A.C., Orizaba, Veracruz, Mexico.
Acta Parasitol. 2025 Sep 3;70(5):189. doi: 10.1007/s11686-025-01125-9.
This study aimed to investigate the influence of benznidazole (BZN) origin on its in vitro potency against various Trypanosoma cruzi strains.
Pure BZN, purified BZN, and the pharmaceutical formulation Abarax were evaluated for their activity against several parasite strains.
Results demonstrated significant variability in BZN's effectiveness, contingent upon both its specific form and the T. cruzi strain under investigation. Half-maximal inhibitory concentrations (IC values) exhibited a wide range, indicating that the potency of BZN is not uniform across all its forms or against all parasite strains.
In conclusion, this study elucidates the complex interaction between BZN and T. cruzi. The parasite's response to BZN can vary even within a single strain, influenced by the drug's specific presentation. These findings underscore the critical importance of considering both parasite diversity and drug formulation when assessing the efficacy of treatments in laboratory assays.
本研究旨在调查苯硝唑(BZN)的来源对其体外抗多种克氏锥虫菌株效力的影响。
对纯苯硝唑、纯化苯硝唑和药物制剂阿巴拉克(Abarax)针对几种寄生虫菌株的活性进行了评估。
结果表明,苯硝唑的有效性存在显著差异,这取决于其具体形式以及所研究的克氏锥虫菌株。半数最大抑制浓度(IC值)呈现出广泛的范围,表明苯硝唑的效力在其所有形式中或针对所有寄生虫菌株时并非一致。
总之,本研究阐明了苯硝唑与克氏锥虫之间的复杂相互作用。即使在单一菌株内,寄生虫对苯硝唑的反应也可能因药物的具体呈现形式而有所不同。这些发现强调了在实验室检测中评估治疗效果时考虑寄生虫多样性和药物制剂的至关重要性。